What does gene-based medicine have to offer?

<p><span data-contrast="auto">This is the latest episode of the free DDW podcast, “</span><span data-contrast="none">What does gene-based medicine have to offer?</span><span data-contrast= "auto">”. It covers two narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW. </span><span data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> </span></p> <p><span data-contrast="auto">The articles are</span> <span data-contrast="none">called “Lipidomics in biomedical research: chance and challenges” and “Exploring gene-based medicine’s true potential”.</span><span data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> </span></p> <p><span data-contrast="none">In the first article, Afrisha Anderson, a Product Manager at Merck KGaA, discusses the opportunities and challenges in lipidomics. In the second article, Christopher Doyle, PhD, Director, IBC Services at WCG, explains why he thinks vaccines for infectious diseases are just the tip of the iceberg when thinking about the promise of gene-based medicines.</span><span data-ccp-props= "{"201341983":0,"335551550":1,"335551620":1,"335559739":160,"335559740":259}"> </span></p>